Pfizer | BiotechTV

top of page

Pfizer Chairman & CEO Dr. Albert Bourla discusses the company's bets on cancer research, VEGF x PD1, #ASCO25 data, and hot button issues affecting the biopharma industry

Dr. Bourla looks back on Pfizers $43B acquisition of Seagen and the company's more recent license of a VEGF x PD1 bispecific. He...

Company News

May 30

Exclusive: Pfizer’s CEO on Q2 earnings

Albert Bourla discusses Q2 earnings, the Seagen deal, Pfizer’s capacity for more deals, GLP-1s, and an update on the NC tornado damage.

Company News

Aug 1, 2023

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.

Learn more about Genezen

bottom of page

Pfizer Chairman & CEO Dr. Albert Bourla discusses the company's bets on cancer research, VEGF x PD1, #ASCO25 data, and hot button issues affecting the biopharma industry

Exclusive: Pfizer’s CEO on Q2 earnings

Follow BiotechTV

Sponsors

Sponsor Spotlight